SEC 13F Intelligence

Duquesne Family Office LLC / TEVA

Duquesne Family Office LLC’s Teva Pharmaceutical Inds Ltd Position

Does Duquesne Family Office LLC own Teva Pharmaceutical Inds Ltd (TEVA)? Yes2.38M shares worth $72M (+2.12% of its 13F portfolio) as of Q1 2026, down from 5.87M shares the prior filed quarter.

Position Value
$72M
Q1 2026
Shares
2.38M
% of Portfolio
+2.12%
Quarters Held
7
currently held

Position History TEVA

Reported value by quarter
Q3 ’24: $26MQ3 ’24Q4 ’24: $198MQ4 ’24Q1 ’25: $229MQ1 ’25Q2 ’25: $268MQ2 ’25Q3 ’25: $335MQ3 ’25Q4 ’25: $183MQ4 ’25Q1 ’26: $72MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.38M$72M+2.12%
Q4 20255.87M$183M+4.08%
Q3 202516.59M$335M+8.25%
Q2 202515.97M$268M+6.57%
Q1 202514.88M$229M+7.47%
Q4 20249.00M$198M+5.33%
Q3 20241.43M$26M+0.87%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Duquesne Family Office LLC’s full portfolio or all institutional holders of TEVA.